RxDoctor Payments Data

Heather Whitehead, NP

Family · Goshen, INNPI 1861054678

Payments from drug & device makers

$696in general payments, 2019–2025

Across 15 payments — averaging $46.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$446
  • Tempus AI, Inc$83
  • GSK$43
  • Merck$32
  • Sanofi Pasteur Inc.$22
  • Progenics Pharmaceuticals, Inc.$19
  • plus $50 from 3 others

What the payments were for

  • Food & beverage$696100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$696 in reported general payments places this provider in the 60th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$9,021
Medicare patients
70
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$69,342
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr32$15,333
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$12,779
Breo ElliptaFluticasone/Vilanterol24$10,775
Spiriva RespimatTiotropium Bromide14$9,393
Stiolto RespimatTiotropium Br/Olodaterol Hcl19$8,990
SymbicortBudesonide/Formoterol Fumarate23$6,509
Arnuity ElliptaFluticasone Furoate13$5,796
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$2,112
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$1,481
Albuterol Sulfate HfaAlbuterol Sulfate61$906
Prednisone31$263
Doxycycline Hyclate16$98
Montelukast Sodium11$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$43$101,246167 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,392 family providers in Indiana.

Other family in Goshen

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →